Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma. | Sci Rep | 2020 | 32161315 | PubTator, text mining | PubMed |
| An Unusual and Facile Synthetic Route to Alumoles. | Angew Chem Int Ed Engl | 2020 | 32160361 | PubTator, text mining | PubMed |
| Progress in Research on the Role of FGF in the Formation and Treatment of Corneal Neovascularization. | Front Pharmacol | 2020 | 32158390 | PubTator, text mining | PubMed |
| Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana. | Mod Pathol | 2020 | 32152520 | PubTator, text mining | PubMed |
| Refractory solitary cervical lymph node metastasis after esophageal squamous cell carcinoma surgery and its successful treatment with immune checkpoint inhibitor: A case report and literature review. | Medicine (Baltimore) | 2020 | 32150096 | PubTator, text mining | PubMed |
| Controlled partial transfer hydrogenation of quinolines by cobalt-amido cooperative catalysis. | Nat Commun | 2020 | 32144242 | PubTator, text mining | PubMed |
| Valproic Acid Promotes Early Neural Differentiation in Adult Mesenchymal Stem Cells Through Protein Signalling Pathways. | Cells | 2020 | 32143420 | PubTator, text mining | PubMed |
| Precision oncology in urothelial cancer. | ESMO Open | 2020 | 32132102 | PubTator, text mining | PubMed |
| Asymmetrically severe internal auditory canal hypoplasia: A case report. | Radiol Case Rep | 2020 | 32123553 | PubTator, text mining | PubMed |
| Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104. | Oncogene | 2020 | 32111983 | PubTator, text mining | PubMed |
| Regulated differentiation of stem cells into an artificial 3D liver as a transplantable source. | Clin Mol Hepatol | 2020 | 32098013 | PubTator, text mining | PubMed |
| Mechanism of Phosphine-Catalyzed Novel Rearrangement of Vinylcyclopropylketone to Cycloheptenone: A DFT Study. | ACS Omega | 2020 | 32095718 | PubTator, text mining | PubMed |
| Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2020 | 32094488 | PubTator, text mining | PubMed |
| ncHMR detector: a computational framework to systematically reveal non-classical functions of histone modification regulators. | Genome Biol | 2020 | 32093739 | PubTator, text mining | PubMed |
| Silver-Triggered Activity of a Heterogeneous Palladium Catalyst in Oxidative Carbonylation Reactions. | Angew Chem Int Ed Engl | 2020 | 32091647 | PubTator, text mining | PubMed |
| Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress? | Oncologist | 2020 | 32043794 | PubTator, text mining | PubMed |
| Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review. | Medicine (Baltimore) | 2020 | 32000458 | PubTator, text mining | PubMed |
| Notch signalling regulates epibranchial placode patterning and segregation. | Development | 2020 | 31988190 | PubTator, text mining | PubMed |
| Easy access to medium-sized lactones through metal carbene migratory insertion enabled 1,4-palladium shift. | Nat Commun | 2020 | 31974346 | PubTator, text mining | PubMed |
| Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer. | Clin Cancer Res | 2020 | 31911548 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=45